BIOSPECIFICS TECHNOLOGIES CORP. CONFIDENTIALITY AND INVENTIONS ASSIGNMENT AGREEMENTConfidentiality and Inventions Assignment Agreement • May 11th, 2020 • Biospecifics Technologies Corp • Pharmaceutical preparations • Delaware
Contract Type FiledMay 11th, 2020 Company Industry JurisdictionIn consideration and as a condition of my employment, or continued employment, by BioSpecifics Technologies Corp., a Delaware corporation (the “Company”), and the compensation now and hereafter paid to me, I hereby agree as follows:
BY EMAIL AND OVERNIGHT MAILBiospecifics Technologies Corp • May 11th, 2020 • Pharmaceutical preparations • Delaware
Company FiledMay 11th, 2020 Industry JurisdictionOn behalf of BioSpecifics Technologies Corp. (“BioSpecifics” or the “Company”), I am pleased to offer you employment with the Company on the terms and subject to the conditions set forth in this letter agreement (the “Agreement”), including satisfactory references, a background check, and submission of satisfactory proof of your identity and your legal authorization to work in the United States:
SEPARATION OF EMPLOYMENT AGREEMENT AND GENERAL RELEASESeparation of Employment Agreement and General Release • May 11th, 2020 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2020 Company Industry JurisdictionThis Agreement sets forth the terms of your separation of employment with Advance Biofactures Corporation (the “Employer”), a wholly-owned subsidiary of BioSpecifics Technologies Corporation (the “Company”). If you understand and agree with these terms, please sign in the space provided below. If you, the Employer and the Company sign below, this will be a legally binding document representing the entire agreement between you, the Employer and the Company regarding the subjects it covers. We will refer to this document as the “Agreement.”
Agreement and General ReleaseAgreement and General Release • May 11th, 2020 • Biospecifics Technologies Corp • Pharmaceutical preparations • California
Contract Type FiledMay 11th, 2020 Company Industry JurisdictionBioSpecifics Technologies Corp. (the “Company”) and Pat Caldwell, his heirs, executors, administrators, successors, and assigns (collectively referred to throughout this agreement as “you” or “your”), hereby enter into this Separation Agreement and General Release (the “Agreement”) to settle all issues arising out of, or related to, your provision of services to the Company and termination thereof. You and the Company agree that: